DaVita Inc. (DVA)
NYSE
Closed
Oct 7, 2026
Day's Range
175.9152 wk Range
101.00Overview - DVA - DaVita Inc.
Key Statistics
Valuation
Enterprise Value
25.94B
P/E (Trailing)
‪15.12‬
P/E (Forward)
‪10.34‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪0.81‬
Price / Book
‪10.70‬
EV / EBITDA
‪9.18‬
Profitability
Gross Margin
‪32.69%‬
Profit Margin
‪6.04%‬
Operating Margin
‪16.06%‬
Return on Assets
‪7.51%‬
Return on Equity
‪88.47%‬
Ownership
Shares Outstanding
63.95M
Float
33.93M
Short % of Shares Outstanding
‪13.25%‬
Held by Insiders
‪46.90%‬
Held by Institutions
‪48.38%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪195.29‬
200-Day Avg
‪168.64‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
8 analysts
Average price target
‪$ 218.43‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DVA - DaVita Inc.
Peers - DVA - DaVita Inc.
Peer Comparison
Compared with companies in Medical Care Facilities listed on NYSE.
Profile Summary - DVA - DaVita Inc.
About
DaVita Inc. is a healthcare services company focused on kidney care, with its core business centered on outpatient dialysis for patients living with chronic kidney disease and end-stage renal disease. DaVita provides in-center hemodialysis, peritoneal dialysis, and home dialysis options, along with related clinical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
